During the past decade, Comprehensive EyeCare of Central Ohio conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Comprehensive EyeCare of Central Ohio" #1 sponsor was "Glaukos Corporation" with 3 trials, followed by "Comprehensive EyeCare of Central Ohio" with 2 trials sponsored, "Refocus Group, Inc." with 2 trials sponsored, "American-European Congress of Ophthalmic Surgery" with 1 trials sponsored and "Kala Pharmaceuticals, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Comprehensive EyeCare of Central Ohio" #1 collaborator was "Glaukos Corporation" with 1 trials as a collaborator and "Icare USA" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Comprehensive EyeCare of Central Ohio" are "Keratoconus" (3 trials), "Corneal Ectasia" (2 trials), "Presbyopia" (2 trials), "Dry Eye Syndromes" (1 trials) and "Evaluation of Corneal Stability Post-applanation" (1 trials). Many other conditions were trialed in "Comprehensive EyeCare of Central Ohio" in a lesser frequency.

Most popular intervention types in "Comprehensive EyeCare of Central Ohio" are "Device" (6 trials), "Drug" (5 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Corneal Collagen Cross-linking" (1 trials), "Icare tonometer" (1 trials), "KPI-121 0.25% Ophthalmic Suspension" (1 trials), "KXL High Power System (10 J)" (1 trials) and "KXL High Power System (2 J)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Comprehensive EyeCare of Central Ohio" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Comprehensive EyeCare of Central Ohio". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 6 completed trials in Comprehensive EyeCare of Central Ohio, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Comprehensive EyeCare of Central Ohio, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".